fbpx
April 2, 2020

REDUCE-IT: CV Benefit Directly Related to EPA Levels REDUCE-IT: CV Benefit Directly Related to EPA Levels

The reduction in cardiovascular (CV) events seen in the REDUCE-IT trial with icosapent ethyl (Vascepa, Amarin), a high-strength formulation of purified eicosapentaenoic acid (EPA), were directly […]
April 2, 2020

Phone-Based CBT Added to Usual Treatment Eases Depression With Parkinson’s Phone-Based CBT Added to Usual Treatment Eases Depression With Parkinson’s

(Reuters Health) – Parkinson’s disease patients with depression who receive telephone-based cognitive behavioral therapy (CBT) in addition to usual treatment may experience a greater improvement in […]
April 1, 2020

COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. The American Heart Association (AHA) has issued new guidance for patients with […]
March 31, 2020

Call for Social Media to ‘Rewrite’ Neurosurgery’s Gender Imbalance Call for Social Media to ‘Rewrite’ Neurosurgery’s Gender Imbalance

The power and reach of social media should be harnessed to correct the current gender imbalance in neurosurgery. Social media could expand the number of mentors […]
March 30, 2020

Class 1 Recall for Medtronic’s Flex Embolization Devices Class 1 Recall for Medtronic’s Flex Embolization Devices

Medtronic is recalling the Pipeline Flex embolization device and Pipeline Flex embolization device with shield technology because the system used to deliver the stent could fracture […]
March 28, 2020

COVID-19: Telemedicine Gets Real, Real Fast Across Neurology COVID-19: Telemedicine Gets Real, Real Fast Across Neurology

For many neurologists, telemedicine is uncharted territory. However, the COVID-19 pandemic has prompted experts in stroke, epilepsy, dementia, Parkinson’s disease (PD), and other subspecialties to offer […]
March 28, 2020

TAILOR-PCI: Clopidogrel Genotyping Trial Narrowly Misses Endpoint TAILOR-PCI: Clopidogrel Genotyping Trial Narrowly Misses Endpoint

The largest trial to date investigating the clinical utility of using genetic testing to detect clopidogrel loss-of-function genotype to guide antiplatelet therapy in patients undergoing percutaneous […]
March 27, 2020

EMA Panel Backs Zolgensma Gene Therapy for SMA EMA Panel Backs Zolgensma Gene Therapy for SMA

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting conditional marketing authorization for onasemnogene abeparvovec (Zolgensma, AveXis […]
March 27, 2020

CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis CHMP Backs Ozanimod (Zeposia) for Multiple Sclerosis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of ozanimod (Zeposia, Celgene Europe BV) for adults […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0